Colorectal cancer screening
https://doi.org/10.21518/2079-701X-2013-10-64-68
Abstract
A brief review is devoted to various aspects of colorectal cancer screening aimed at detection at early stages in risk groups.
About the Authors
G. I. Storozhakov
Subdepartment of hospital therapy No. 2, general medicine department at Pirogov Russian National Research Medical University, Russia's Ministry of Health, Moscow
Russian Federation
Russian Federation
E. I. Pozharitskaya
Subdepartment of hospital therapy No. 2, general medicine department at Pirogov Russian National Research Medical University, Russia's Ministry of Health, Moscow
Russian Federation
Russian Federation
I. G. Fyodorov
City clinical hospital No. 12, Moscow Healthcare Department; Subdepartment of hospital therapy No. 2, general medicine department at Pirogov Russian National Research Medical University, Russia's Ministry of Health, Moscow
Russian Federation
Russian Federation
References
1. Земляной В.П., Трофимова Т.Н., Непомнящая С.Л. [и др.] Современные методы диагностики и оценки степени распространенности рака ободочной и пря-мой кишки // Практ. онкол. 2005. №2. С. 71–80.
2. Black R.J., Sharp L., Kendruck S.W. Trends in Cancer Survival in Scotland 1968-1990 // Edinbourgh: National Health Service in Scotland, Information & Statistics Division. 1993.
3. Levi F., Lucchini F., Negri E. et al. Cancer mortality in the European Union, 1988-1997: The fall may approach 80000 deaths a year // J. Cancer. 2002. Vol. 98. P. 636–637.
4. Burt R.W., Bishop D.T., Lynch H.T. et al. Risk and surveillance of individuals with heritable factors for colorectal cancer // Bull World Health Organ. 1990. Vol. 68. Р. 655–665.
5. Руководство по медицинской профилактике / под ред. Р.Г. Оганова, Р.А. Хальфина. М.: ГЭОТАР-Медиа, 2007. С. 464.
6. Анисимов В.Н., Арутюнян А.В., Хавинсон В.Х. Влияние мелатонина и эпита-ламина на активность антиоксидантных защитных систем у крыс // Докл. РАН. 1997. Т. 352. С. 831–833.
7. Boyle P., Leon M.E. Epidemiology of colorectal cancer // Brit. Med. Bull. 2002. Vol. 64. P. 1–25.
8. Collins J.F., Lieberman D.A., Durbin T.E. еt al. Accuracy of screening for fecal oc-cult blood on a single stool sample obtained by digital rectal examination: a com-parison with recommended sampling practice // Ann. Intern. Med. 2005. Vol. 142. Р. 81–85.
9. Allison J.E., Sakoda L.C., Levin T.R. et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics // J. Natl. Cancer Inst. 2007. Vol. 99. Р. 1462–1470.
10. Сolorectal cancer screening World Gastroenterology Organisation/International Di-gestive Cancer Alliance Practice Guidelines http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/06_colorectal cancer_screening. pdf.
11. Greenberger N.J., Blumberg R.S., Burakoff R. et al. Current Diagnosis and Treat-ment // Gastroenterol. Hepatol. Endoscopy. 2009. Vol. 22. Р. 263–264.
12. Ahlquist D.A., Skoletsky J.E., Boynton K.A. et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel // Gastroenterol. 2000. Vol. 119. Р. 1219–1227.
13. Gold., Freedman S.O. Specific carcinoembrionic antigens of the human digestive system // 11 J. Exp. Med. 1965. Vol. 122.P. 467–481.
14. Uedo N., Isbikawa H., Narahara H. et al. // Cancer Detect. Prev. 2000. Vol. 24. P. 290–294.
15. Скворцов С.В., Храмченко И.М., Кушликский Н.Е. Опухолевые маркеры в оценке степени распространенности опухолевого процесса при злокачествен-ных новообразованиях желудочно-кишечного тракта // Клин. лаб. диагн. 1999. №9. С. 26.16.
16. Mavligit G.M., Eitrov Z. // Am. J. Clin. Oncol. 2000. Vol. 23. P. 213–215.
17. Савватеева Е.Н., Дементьева Е.И. Биологический микрочип для одновремен-ного количественного иммунологического анализа маркеров онкологических заболеваний в сыворотке крови человека // Бюл. экспер. Биол: ежемесячный международный научно-теоретический журнал. 2009. №6. С. 679–683.
18. Popat S., Hubner R., Houlston R.S. Systematic review of microsatellite instability and colorectal cancer prognosis // J. Clin. Oncol. 2005. Vol. 86. Р. 609–618.
19. Munro A.J., Lain S., Lane D.P. P53 abnormalities and outcomes in colorectal can-cer: a systematic review // Br. J. Cancer. 2005. Vol. 14. Р. 434–444.
20. Andreyev H.J., Norman A.R., Cunningham D. еt al. Kirsten ras mutations in patients with colorectal cancer: the multicenter «RASCAL» study. 1998. Vol. 69. Р. 675–684.
21. Andreyev H.J., Norman A.R., Cunningham D. еt al. Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study. 2001. Vol. 85. Р. 692–696.
22. Sonnenberg A., Delco F., Bauerfeind P. Is virtual colonoscopy a cost effective op-tion to screen for colorectal cancer? // Am. J. Gastroenterol. 1999. Vol. 94. P. 2268–2274.
Review
For citations:
Storozhakov GI, Pozharitskaya EI, Fyodorov IG. Colorectal cancer screening. Meditsinskiy sovet = Medical Council. 2013;(10):64-68. (In Russ.) https://doi.org/10.21518/2079-701X-2013-10-64-68
Views:
452
Email this article 